28 September 2010 -- UK-based global Clinical Research Organisation (CRO), ClinTec International has further established its US presence with the appointment of new Executive Vice President, Dr Dianne Kikta.
Dr Kikta is based in the Philadelphia area and will augment ClinTec’s US operations and Global HQ management team to offer prospective pharmaceutical, biotech and medical device client’s guidance on their drug development and resourcing strategy with an emphasis on the emerging markets where ClinTec has a strong base.
Dr Kikta brings to ClinTec a wealth of experience from the pharmaceutical industry having worked for Wyeth for over 20 years, most recently as Vice President of Global Clinical Strategic Resourcing where she was responsible for providing strategic oversight of flexible resourcing to efficiently deliver clinical research services, especially through off-shoring and outsourcing.
Regarding her new role, Dr Kikta stated “I am excited to be a part of ClinTec, a growing CRO that doesn’t only work in support of the pharmaceutical industry, but also provides solutions through innovative resourcing and processes. I look forward to contributing to ClinTec’s future success by applying my experience in innovative global resourcing models and various strategic initiatives from Wyeth.
Having established Wyeth’s highly successful clinical research centre in India through a unique partnership approach, I have a firm understanding of the opportunities within the emerging markets for continued use of unique resourcing models. Working with ClinTec will allow me to use my numerous years of experience in one company to now influence many aspects of the industry.”
Senior Director of Corporate Development, Bobby Bal remarked “We are pleased to have Dianne on board to facilitate the next wave of strategic outsourcing partnerships with our growing US customer base. We believe that entering into creative discussion with the US pharmaceutical industry will help alleviate some of the immediate R&D pressures on cost and productivity and Dianne’s specific experience in global solution development will be of great use to our clients”.
About ClinTec International
ClinTec International is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec International has a presence in 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.
In addition to ClinTec International’s vast expertise in oncology, the organisation has also conducted over 400 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec International’s ‘fast, flexible and focused? approach to clinical research ensures an added advantage to the drug development process. The organisations range of services includes Clinical Monitoring and Project Management, Regulatory Affairs, Medical Writing, Data Management and Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Training courses.
For further information please contact:
Bobby Bal, Senior Director Corporate Development, ClinTec International Headquarters: +44 (0) 141 226 1120 or email@example.com
For more information about ClinTec, please visit www.clintec.com
For media enquiries: please contact Tristan Jervis on: 00 44 207 861 3019. E-mail: firstname.lastname@example.org